FTSE 100 falls on healthcare, energy weakness; cooling wage growth fuels rate cut bets
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
FTSE 100 down 0.8%, FTSE 250 flat
AstraZeneca drops after lung cancer drug trial setback
Centamin soars after AngloGold Shanti's buyout offer
UK pay growth cools to more than two-year low
IQE expects FY profit at lower end of market view, shares down
Updated at 1545 GMT
By Khushi Singh and Purvi Agarwal
Sept 10 (Reuters) -London's FTSE 100 ended lower on Tuesday, led by a sell-off in healthcare and energy shares, while cooling wage growth in the UK cemented bets for further interest rate cuts by the Bank of England.
The blue-chip FTSE 100 .FTSE fell 0.8%, after logging its best day in over a month on Monday. The mid-cap FTSE 250 .FTMC ended the session flat.
The pharma and biotech sector .FTNMX201030 slipped 1.5% to hit its lowest level in more than a month, weighed down by AstraZeneca AZN.L, which shed 2.4%.
Detailed results from one of the drugmaker's key lung cancer trials on Monday showed that its experimental precision drug did not significantly improve overall results in patients.
Heavyweight energy shares .FTNMX601010 lost 1.7% after Brent crude futures prices fell below $70 a barrel for the first time since December 2021, after OPEC+ revised down its demand forecast for this year and 2025. O/R
The automobiles and parts .FTNMX401010 index was the top sectoral decliner, down 2.9%, followed by a 1.9% drop in the banks index .FTNMX301010.
Precious metal miners .FTNMX551030 led gains with a 6.7% rise, marking its best day since Nov. 4, 2022, after shares in gold miner Centamin CEY.L surged 22.9%.
AngloGold Ashanti AU.N will buy the Egypt-focused smaller rival in a $2.5 billion stock and cash deal.
Rate-sensitive real estate and homebuilder indexes were also among the top gainers after data showed British pay growth cooled in the three months to July to a more than two-year low and employment shot higher.
Economists suggest the data keeps the BoE on track for a November rate cut.
Among individual stocks, Alpha Group ALPH.L fell 11.1% to the bottom of the mid-caps index after the financial solutions provider announced chief executive succession plans. Clive Kahn will succeed founder Morgan Tillbrook as CEO from January 2025.
IQE IQE.L tumbled 19.2% after the semiconductor wafer maker said it saw its annual performance at the lower end of analysts' expectations.
Reporting by Khushi Singh, Purvi Agarwal in Bengaluru; Editing by Mrigank Dhaniwala and Jonathan Oatis
For related prices, Reuters users may click on - * UK stock report .L FTSE index: 0#.FTS6 techMARK 100 index: .FTT1X FTSE futures: 0#FFI: Gilt futures: 0#FLG: Smallcap index: .FTSC FTSE 250 index: .FTMC FTSE 350 index: .FTLC Market digest: .AD.L Top 10 by vol: .AV.L Top price gainers: .NG.L Top % gainers: .PG.L Top price losers: .NL.L Top % losers: .PL.L * For related news, click on - * UK hot stocks: HOT and GB Wall Street: .N Gilts report: GB/ Euro bond report GVD/EUR Pan European stock report: .EU Tokyo stocks: .T HK stocks: .HK Sterling report: GBP/ Dollar report: USD/ * For company prices, click on - * Company directory: UKEQ By sector: FTAX * For pan-European market data, click on - * European Equities speed guide................ EUR/EQUITY FTSE Eurotop 300 index........................... .FTEU3 DJ STOXX index................................... .STOXX Top 10 STOXX sectors........................ .PGL.STOXXS Top 10 EUROSTOXX sectors................... .PGL.STOXXES Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S Top 25 European pct gainers.................... .PG.PEUR Top 25 European pct losers..................... .PL.PEUR
Aset Berkaitan
Berita Terkini
Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.
Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.
Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.
